{"url":"https://lda.senate.gov/api/v1/filings/d182e680-646c-4cd3-a3d9-e66ea27d66b4/","filing_uuid":"d182e680-646c-4cd3-a3d9-e66ea27d66b4","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2021,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/d182e680-646c-4cd3-a3d9-e66ea27d66b4/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Michael J Yaki","dt_posted":"2021-10-04T16:46:29.620000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"Po Box 387, The Sea Ranch, CA 95497","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"The Sea Ranch","registrant_state":"CA","registrant_zip":"95497","registrant":{"id":401105649,"url":"https://lda.senate.gov/api/v1/registrants/401105649/","house_registrant_id":null,"name":"MICHAEL YAKI CONSULTING","description":"Consulting","address_1":"Po Box 387, The Sea Ranch, CA 95497","address_2":null,"address_3":null,"address_4":null,"city":"The Sea Ranch","state":"CA","state_display":"California","zip":"95497","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MICHAEL YAKI","contact_telephone":"+1 415-601-4008","dt_updated":"2023-09-11T13:25:20.039032-04:00"},"client":{"id":205825,"url":"https://lda.senate.gov/api/v1/clients/205825/","client_id":12,"name":"ANTIMICROBIALS WORKING GROUPS","general_description":"Antimicrobial research and development","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-05-06"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Discuss w House and Senate staff on funding for antimicrobial commercialization","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":87825,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":"JOHN","last_name":"YAKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Discuss w House and Senate staff on funding for antimicrobial commercialization","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":87825,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":"JOHN","last_name":"YAKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Discussion w House and Senate staff on funding for Antimicrobial commercialization","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":87825,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":"JOHN","last_name":"YAKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}